Toll-like receptor-Janus kinase-Signal transducer and activator of transcription signaling network (TLR-JAK-STAT)

The Toll-like receptor-Janus kinase-Signal transducer and activator of transcription (TLR-JAK-STAT) signaling network is a complex regulatory axis that integrates innate immune sensing with downstream gene expression [1]. Toll-like receptors (TLRs) detect pathogen-associated molecular patterns and initiate intracellular signaling that leads to the expression of pro-inflammatory cytokines [1]. These cytokines, such as interferons and interleukins, subsequently bind to their cognate receptors to activate the Janus kinase (JAK) family of enzymes [2]. Activated JAKs then phosphorylate Signal Transducer and Activator of Transcription (STAT) proteins, which dimerize and translocate to the nucleus to function as transcription factors [3]. This network is essential for orchestrating immune responses, but its chronic activation is a key driver of autoimmune diseases like rheumatoid arthritis and psoriasis [4]. Furthermore, aberrant TLR-JAK-STAT signaling is frequently observed in various cancers, where it promotes tumor cell survival, proliferation, and immune evasion [4]. Pharmacological targeting of this network primarily involves the use of JAK inhibitors (jakinibs) to block cytokine signaling or TLR modulators to adjust the initial immune trigger [5]. Clinical use of these agents has proven effective in managing inflammatory conditions, although they carry risks of systemic immunosuppression and increased susceptibility to infections [5].

Other names

TLR-JAK-STAT axisTLR-JAK-STAT pathwayTLR-mediated JAK-STAT activation

Inhibition of Janus kinases (JAK1, JAK2, JAK3, TYK2) to block downstream STAT phosphorylation and gene transcription; modulation of Toll-like receptors (TLRs) to regulate the production of cytokines that activate the JAK-STAT axis.